562 related articles for article (PubMed ID: 8960561)
1. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
[TBL] [Abstract][Full Text] [Related]
2. Nucleosides and nucleotides. 175. Structural requirements of the sugar moiety for the antitumor activities of new nucleoside antimetabolites, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and -uracil1.
Hattori H; Nozawa E; Iino T; Yoshimura Y; Shuto S; Shimamoto Y; Nomura M; Fukushima M; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Jul; 41(15):2892-902. PubMed ID: 9667977
[TBL] [Abstract][Full Text] [Related]
3. [Antitumor effect and mechanism of a novel multifunctional nucleoside, 3'-ethynylnucleoside, on human cancers].
Tanaka M; Tabata S; Matsuda A; Fukushima M; Eshima K; Sasaki T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):476-82. PubMed ID: 9063487
[TBL] [Abstract][Full Text] [Related]
4. Antitumor mechanisms and metabolism of the novel antitumor nucleoside analogues, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil.
Takatori S; Kanda H; Takenaka K; Wataya Y; Matsuda A; Fukushima M; Shimamoto Y; Tanaka M; Sasaki T
Cancer Chemother Pharmacol; 1999; 44(2):97-104. PubMed ID: 10412942
[TBL] [Abstract][Full Text] [Related]
5. A crucial role of uridine/cytidine kinase 2 in antitumor activity of 3'-ethynyl nucleosides.
Murata D; Endo Y; Obata T; Sakamoto K; Syouji Y; Kadohira M; Matsuda A; Sasaki T
Drug Metab Dispos; 2004 Oct; 32(10):1178-82. PubMed ID: 15280220
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic mechanisms of new antitumor nucleoside analogues, 3'-ethynylcytidine (ECyd) and 3'-ethynyluridine (EUrd).
Kanda H; Takatori S; Matsuda A; Sasaki T; Tanaka M; Fukushima M; Wataya Y
Nucleic Acids Symp Ser; 1997; (37):137-8. PubMed ID: 9586037
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
9. PK-PD modeling of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine and the enhanced antitumor effect of its phospholipid derivatives in long-circulating liposomes.
Takada A; Kamiya H; Shuto S; Matsuda A; Harashima H
Int J Pharm; 2009 Jul; 377(1-2):52-9. PubMed ID: 19426792
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory mechanisms of 1-(3-C-ethynyl-beta-D-ribopentofuranosyl)uracil (EUrd) on RNA synthesis.
Yokogawa T; Naito T; Kanda H; Takatori S; Takenaka K; Sasaki T; Matsuda A; Fukushima M; Kim HS; Wataya Y
Nucleosides Nucleotides Nucleic Acids; 2005; 24(3):227-32. PubMed ID: 15892261
[TBL] [Abstract][Full Text] [Related]
11. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106)1: antitumor effect and mechanism of action.
Azuma A; Matsuda A; Sasaki T; Fukushima M
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):609-19. PubMed ID: 11563078
[TBL] [Abstract][Full Text] [Related]
12. Anticancer mechanisms of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl) cytosine (ECyd, TAS-106).
Naito T; Yokogawa T; Kim HS; Futagami M; Wataya Y; Matsuda A; Fukushima M; Kitade Y; Sasaki T
Nucleic Acids Res Suppl; 2002; (2):241-2. PubMed ID: 12903195
[TBL] [Abstract][Full Text] [Related]
13. 1-(3-C-Ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), a novel potent inhibitor of RNA polymerase, potentiates the cytotoxicity of CDDP in human cancer cells both in vitro and in vivo.
Kazuno H; Fujioka A; Fukushima M; Wataya Y; Matsuda A; Sasaki T
Int J Oncol; 2009 May; 34(5):1373-80. PubMed ID: 19360349
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 4,6-dideoxy-3-fluoro-2-keto-beta-D-glucopyranosyl analogues of 5-fluorouracil, N6-benzoyl adenine, uracil, thymine, N4-benzoyl cytosine and evaluation of their antitumor activities.
Manta S; Tsoukala E; Tzioumaki N; Kiritsis C; Balzarini J; Komiotis D
Bioorg Chem; 2010 Apr; 38(2):48-55. PubMed ID: 20018340
[TBL] [Abstract][Full Text] [Related]
15. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
Ogawa A; Tanaka M; Sasaki T; Matsuda A
J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
[TBL] [Abstract][Full Text] [Related]
16. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
Matsuda A; Fukushima M; Wataya Y; Sasaki T
Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of 4'-C-ethynyl-beta-D-arabino- and 4'-C-ethynyl-2'-deoxy-beta- D-ribo-pentofuranosyl pyrimidines, and their biological evaluation.
Kohgo S; Horie H; Ohrui H
Biosci Biotechnol Biochem; 1999 Jun; 63(6):1146-9. PubMed ID: 10427708
[TBL] [Abstract][Full Text] [Related]
18. Cellular and biochemical mechanisms of the resistance of human cancer cells to a new anticancer ribo-nucleoside, TAS-106.
Shimamoto Y; Kazuno H; Murakami Y; Azuma A; Koizumi K; Matsuda A; Sasaki T; Fukushima M
Jpn J Cancer Res; 2002 Apr; 93(4):445-52. PubMed ID: 11985795
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
20. Unsaturated dideoxy fluoro-ketopyranosyl nucleosides as new cytostatic agents: a convenient synthesis of 2,6-dideoxy-3-fluoro-4-keto-beta-D-glucopyranosyl analogues of uracil, 5-fluorouracil, thymine, N4-benzoyl cytosine and N6-benzoyl adenine.
Manta S; Tzioumaki N; Tsoukala E; Panagiotopoulou A; Pelecanou M; Balzarini J; Komiotis D
Eur J Med Chem; 2009 Nov; 44(11):4764-71. PubMed ID: 19595489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]